TNFRSF12A and gastric adenocarcinoma: TNFRSF12A+ CAF plays a key role in the immunosuppression of intestinal-type gastric adenocarcinoma (IGAC) (a type of STAD) acts as a key mediator in immunosuppression and has potential as an immunomodulator (48).